362 related articles for article (PubMed ID: 37463688)
1. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Risk Factors for Mortality in Critical Coronavirus Disease 2019 Patients 50 Years of Age or Younger During the Delta Wave: Comparison With Patients > 50 Years in Korea.
Shi HJ; Nham E; Kim B; Joo EJ; Cheong HS; Hong SH; Hyun M; Kim HA; Jang S; Rhee JY; Kim J; Kim S; Cho HK; Wi YM; Cheon S; Kim YS; Lim S; Seok H; Jung SI; Eom JS; Peck KR
J Korean Med Sci; 2022 Jun; 37(22):e175. PubMed ID: 35668685
[TBL] [Abstract][Full Text] [Related]
3. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.
Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME
BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Paxlovid, an Oral Antiviral Drug, Against the Omicron BA.5 Variant in Korea: Severe Progression and Death Between July and November 2022.
Kim JM; Yoo MG; Bae SJ; Kim J; Lee H
J Korean Med Sci; 2023 Jul; 38(27):e211. PubMed ID: 37431541
[TBL] [Abstract][Full Text] [Related]
9. A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study.
Li JX; Liao PL; Wei JC; Hsu SB; Yeh CJ
Front Public Health; 2023; 11():1143650. PubMed ID: 37799149
[TBL] [Abstract][Full Text] [Related]
10. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
11. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
[TBL] [Abstract][Full Text] [Related]
12. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
medRxiv; 2022 Jul; ():. PubMed ID: 35898339
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and omicron variants in tertiary hospitals of Japan.
Sakuramoto K; Wada D; Maruyama S; Muroya T; Saito F; Nakamori Y; Kuwagata Y
BMC Infect Dis; 2024 Feb; 24(1):223. PubMed ID: 38374034
[TBL] [Abstract][Full Text] [Related]
16. The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.
Kim K; Cho K; Song J; Rahmati M; Koyanagi A; Lee SW; Yon DK; Il Shin J; Smith L
J Med Virol; 2023 Feb; 95(2):e28522. PubMed ID: 36691933
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study.
Han HJ; Kim SW; Kim H; So J; Lee EJ; Lim YM; Lee JH; Lee MA; Kim BJ; Baek SH; Lee HS; Sohn E; Kim S; Park JS; Kang M; Park HJ; Yoon BA; Kim JK; Seok HY; Kim S; Min JH; Chung YH; Cho JH; Kim JE; Oh SI; Shin HY
J Korean Med Sci; 2024 May; 39(18):e150. PubMed ID: 38742290
[TBL] [Abstract][Full Text] [Related]
18. Severity of COVID-19 among Residents in Aged Care Facilities in Victoria, Australia: A Retrospective Cohort Study Comparing the Delta and Omicron Epidemic Periods.
Muleme M; McNamara BJ; Ampt FH; Baptista M; Dittmer J; Osborne A; Ahmed H; Hales G; Kabwe M; Main S; Moreira C; Silverstein S; Sotheran E; Athan E; Johnson PDR; O'Brien DP; Sullivan SG
J Am Med Dir Assoc; 2023 Apr; 24(4):434-440.e5. PubMed ID: 36806486
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan.
Suzuki K; Ichikawa T; Suzuki S; Tanino Y; Kakinoki Y
PeerJ; 2022; 10():e13762. PubMed ID: 35935257
[TBL] [Abstract][Full Text] [Related]
20. Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to the emerging variant: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations.
Ryu B; Shin E; Kim DH; Lee H; Choi SY; Kim SS; Kim IH; Kim EJ; Lee S; Jeon J; Kwon D; Cho S
BMC Infect Dis; 2024 Jan; 24(1):1. PubMed ID: 38166696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
